Journal of Applied Physiology Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 98: 482-488, 2005. First published October 1, 2004; doi:10.1152/japplphysiol.00895.2004
8750-7587/05 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Supplementary Material
Right arrow All Versions of this Article:
98/2/482    most recent
00895.2004v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bickel, C. S.
Right arrow Articles by Adams, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bickel, C. S.
Right arrow Articles by Adams, G. R.

Time course of molecular responses of human skeletal muscle to acute bouts of resistance exercise

C. Scott Bickel,4 Jill Slade,1 Ed Mahoney,1 Fadia Haddad,2 Gary A. Dudley,1,3 and Gregory R. Adams2

1Department of Exercise Science, The University of Georgia, Athens, Georgia; 2Department of Physiology and Biophysics, University of California, Irvine, California; 3Crawford Research Institute, Shepherd Center, Atlanta, Georgia; and 4Department of Physical Therapy, Louisiana State University, New Orleans, Louisiana

Submitted 18 August 2004 ; accepted in final form 24 September 2004


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Resistance exercise (RE) training, designed to induce hypertrophy, strives for optimal activation of anabolic and myogenic mechanisms to increase myofiber size. Clearly, activation of these mechanisms must precede skeletal muscle growth. Most mechanistic studies of RE have involved analysis of outcome variables after many training sessions. This study measured molecular level responses to RE on a scale of hours to establish a time course for the activation of myogenic mechanisms. Muscle biopsy samples were collected from nine subjects before and after acute bouts of RE. The response to a single bout was assessed at 12 and 24 h postexercise. Further samples were obtained 24 and 72 h after a second exercise bout. RE was induced by neuromuscular electrical stimulation to generate maximal isometric contractions in the muscle of interest. A single RE bout resulted in increased levels of mRNA for IGF binding protein-4 (84%), MyoD (83%), myogenin (~3-fold), cyclin D1 (50%), and p21-Waf1 (16-fold), and a transient decrease in IGF-I mRNA (46%). A temporally conserved, significant correlation between myogenin and p21 mRNA was observed (r = 0.70, P ≤ 0.02). The mRNAs for mechano-growth factor, IGF binding protein-5, and the IGF-I receptor were unchanged by RE. Total skeletal muscle RNA was increased 72 h after the second serial bout of RE. These results indicate that molecular adaptations of skeletal muscle to loading respond in a very short time. This approach should provide insights on the mechanisms that modulate adaptation to RE and may be useful in evaluating RE training protocol variables with high temporal resolution.

neuromuscular electrical stimulation; myogenin; p21; MyoD


IT IS GENERALLY ACCEPTED THAT resistance exercise (RE) elicits adaptations that result in increased skeletal muscle size and changes in contractile characteristics. The majority of these adaptations take the form of increases in myofiber size (e.g., Ref. 20) and alterations in the mix of contractile and metabolic proteins present in these cells [e.g., isoform shifts, etc. (14)]. Alterations in the types and amounts of cellular proteins in myofibers can involve changes in gene transcription and translation. In vitro and in vivo studies have identified a number of specific mRNAs in skeletal muscles that change in response to increased loading (15, 18, 21, 24, 37, 40).

The concept underlying RE training, designed to induce skeletal muscle hypertrophy, is that the correct selection of program variables, e.g., frequency, intensity, and duration of individual sessions, results in cellular and molecular responses that promote the growth process. We have shown that individual sessions of high-force actions common during an RE session elicit cellular and molecular responses in rodents that have characteristic temporal patterns of increase and decline (24). In those studies, we also found that subsequent sessions of high-force actions result in the summation of these responses. The magnitude of summation is sensitive to the time interval allowed between RE sessions (24). In a subsequent study, we found that molecular responses to high-force RE sometimes differ between skeletal muscle of spinal cord-injured and ambulatory individuals (13) but are generally similar.

In vitro and in vivo studies indicate that two primary processes are involved with the compensatory hypertrophy response in mammalian skeletal muscles. The first are anabolic processes necessary for the accretion of protein to support myofiber enlargement. The second involves proliferation of satellite cells that appear to be necessary to provide myonuclei to the enlarging myofibers (7, 41, 42, 4547, 49). The cellular and molecular mechanisms underlying these processes have been extensively characterized in a number of cell types, particularly in cell culture settings. In particular, the steps associated with the initiation of cellular proliferation are generally well established (e.g., can be found in cell biology textbooks). Based on these well-characterized processes, we have previously used representative mRNAs as markers of potential myogenic responses to high-force actions of skeletal muscle in rodents and humans (2–4, 13, 24). For example, increased expression of myogenin is often associated with committed stages of myoblast differentiation and fusion (22, 27, 44, 48, 53). Similarly, the cyclin-dependent kinase inhibitor p21 is associated with withdrawal from the cell cycle and, often, subsequent cell differentiation (22, 33). Together, these markers are often used as an indication of myogenic cell differentiation in settings associated with muscle formation or muscle hypertrophy (2, 4, 22, 24, 33). Potential alterations in cellular proliferation can be inferred from changes in key cell cycle regulatory agents such as cyclin D1 (38). In the present study, we used this myogenic marker approach to characterize the molecular level responses of human skeletal muscles to acute bouts of RE (maximal isometric contractions).

Following a protocol similar to that used in our previous rodent studies, we found that RE induced similar molecular level changes in human skeletal muscles in response to a single exercise bout (24).

The in vivo validation of loading-sensitive cellular and molecular responses will help to elucidate the processes that have been assumed to take place as a result of RE training but, until now, have not been systematically investigated. This understanding will, in turn, allow for the further elucidation of the regulatory mechanisms that control and coordinate the suite of adaptations that comprise the compensatory hypertrophy response and, at least in a laboratory setting, provide a mechanism by which different RE training protocols and modalities (e.g., static vs. dynamic, concentric vs. eccentric, etc.) could be objectively evaluated.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Subjects.   Nine (age 25 ± 4 yr, height 178 ± 8 cm, weight 70 ± 3 kg, means ± SE; 6 men, 3 women) able-bodied subjects participated in this study. The subjects had no history of lower extremity pathology and signed informed consent before testing. Subjects were recreationally active and not currently involved in lower extremity RE. The methods were approved by the Institutional Review Boards of The University of Georgia, Shepherd Center, and the University of California-Irvine.

RE protocol.   Neuromuscular electrical stimulation (NMES) was chosen to ensure maximal activation of the vastus lateralis (VL) muscle and to avoid the complication associated with voluntary muscle activation (e.g., recurrent inhibition, motor unit cycling, etc.). It has previously been demonstrated that this method of muscle activation compares favorably with voluntary muscle contraction for the development of muscle hypertrophy and increased strength (e.g., Ref. 43). The VL muscle was stimulated, as described previously (5, 16, 29, 43). Subjects were seated in a custom-built chair with the hip and knee secured at ~70° of flexion. The leg was firmly secured to a rigid lever arm with an inelastic strap to ensure that the knee extensors could only perform isometric contractions. As with our previous animal studies, isometric mode contractions were used to minimize the potential for skeletal muscle injury (24). The moment arm was established by placing a load cell (model 2000A, Rice Lake Weighing Systems, Rice Lake, WI) parallel to the line of pull and perpendicular to the lever arm. Torque was recorded from the load cell by using a MacLab analog-to-digital converter (model ML 400, ADInstruments, Milford, MA) sampling at 100 Hz and interfaced with a portable Macintosh computer (Apple Computer, Cupertino, CA). Two 8 x 10-cm surface electrodes (Uni-Patch, Wabasha, MN) were placed on the skin over the proximal and distal portions of the VL muscle. Using magnetic resonance imaging, our laboratory has previously demonstrated that this electrode placement will maximally recruitment primarily the VL muscle (6, 29). A commercial stimulator (TheraTouch model 4.7, Rich-Mar, Inola, OK) was used for NMES. The initial torque was determined in the following manner. Subjects performed a maximum voluntary contraction (MVC) for isometric knee extension before NMES. The subjects were highly motivated, and all had prior experience with performing knee extension MVC. We have previously established that the VL muscle constitutes roughly 30% of the total quadriceps group cross-sectional area (28). Accordingly, NMES current sufficient to elicit ~30% of the observed isometric knee extension MVC (generated by the entire quadriceps group) was determined and used for the subsequent NMES protocol. This 30% index value provides a means to avoid the unnecessary delivery of excess current that may activate synergistic muscles that were not the focus of this study. The NMES protocol consisted of 5-s contractions separated by 15 s for 30 min at these previously determined current levels. Contractions were evoked with 50-Hz trains of 450-µs biphasic pulses.

Biopsy technique.   Biopsies were taken from the VL by using the percutaneous biopsy technique, as done previously (16, 28). To reduce the number of serial biopsies, the preexercise sample was collected from the nonexercised muscle. To minimize the potential for interference, any serial biopsy samples were collected at least 2 cm from previous biopsy sites. Samples were immediately cooled with liquid nitrogen and then stored at –70°C until analyzed.

Experimental timeline.   See Fig. 1. At time 0, a biopsy sample was collected from the VL of the nontreatment leg. This approach was used to ensure that any changes seen in the 12-h biopsy samples could not be attributable to a previous biopsy procedure. The use of the contralateral limb as a control has been previously validated (e.g., Ref. 35). The subjects then completed the initial 30-min bout of NMES-induced RE. At 12 h postexercise, a biopsy sample was collected from the VL of the exercised leg. At 24 h, a second biopsy was collected from the previously exercised VL, and the NMES-induced RE exercise was then repeated. Biopsy samples were then collected from the exercised VL 48 and 96 h post-NMES-induced RE, relative to time 0 (24 and 72 h after the second bout of RE).



View larger version (6K):
[in this window]
[in a new window]
 
Fig. 1. Experimental protocol timeline. Resistance exercise (RE) = 30 min of neuromuscular electrical stimulation-induced RE. Note that the 48- and 96-h samples are relative to time 0 and as such were 24 and 72 h after the second bout of RE.

 
Total RNA isolation.   Measurements of total RNA content provide insights on the translational capacity of tissue. Total RNA was extracted from preweighed frozen muscle samples by using the TRI Reagent (Molecular Research Center, Cincinnati, OH), according to the company's protocol, which is based on the method described by Chomczynski and Sacchi (17). Extracted RNA was precipitated from the aqueous phase with isopropanol and, after washing with ethanol, dried and suspended in a known volume of nuclease-free water. The RNA concentration was determined by optical density at 260 nm (using a 260-nm optical density unit equivalent to 40 µg/ml). The muscle total RNA concentration is calculated based on total RNA yield and the weight of the analyzed sample. The RNA samples were stored frozen at –80°C to be used subsequently in determining specific mRNA expression with the use of relative RT-PCR procedures.

RT.   One microgram of total RNA was reverse transcribed for each muscle sample using the SuperScript II RT from GIBCO BRL and a mix of oligo(dT) (100 ng per reaction) and random primers (200 ng per reaction) in a 20-µl total reaction volume at 45°C for 50 min, according to the provided protocol. At the end of the RT reaction, the tubes were heated at 90°C for 5 min to stop the reaction and then were stored at –80°C until they were used in the PCR reactions for specific mRNA analyses (see below).

PCR.   A relative RT-PCR method using 18S as an internal standard (Ambion, Austin, TX) was applied to study the expression of mRNAs for IGF-I, mechano-growth factor (MGF), IGF-I receptor, IGF binding proteins (BP)-4 and -5, myogenin, cyclin D1, and p21. The sequence for the various primers used for the specific target mRNAs has been published previously (13). Primers were designed using Primer Select computer program (DNA Star), purchased from Life Technology, GIBCO, and were tested for their compatibility with the alternate 18S primers.

In each PCR reaction, 18S ribosomal RNA was coamplified with the target cDNA (mRNA) to serve as an internal standard and to allow correction for differences in starting amounts of total RNA.

For the 18S amplification, we used the Alternate 18S Internal Standards (Ambion), which yields a 324-bp product. The 18S primers were mixed with competimers at an optimized ratio that could range from 1:4 to 1:10, depending on the abundance of the target mRNA. Inclusion of 18S competimers was necessary to bring down the 18S signal, which allows its linear amplification to the same range as the coamplified target mRNA (Ambion, Relative RT-PCR kit protocol).

For each specific target mRNA, the RT and PCR reactions were carried under identical conditions by using the same reagent premix for all of the samples to be compared in the study. To validate the consistency of the analysis procedures, at least one representative from each group was included in each RT-PCR run.

One microliter of each RT reaction (0- to 10-fold dilution, depending on target mRNA abundance) was used for the PCR amplification. The PCR reactions were carried out in the presence of 2 mM MgCl2 by using standard PCR buffer (GIBCO), 0.2 mM dNTP, 1 µM specific primer set, 0.5 µM 18S primer-competimer mix, and 0.75 unit of DNA Taq polymerase (GIBCO) in 25-µl total volume. Amplifications were carried out in a Stratagene Robocycler with an initial denaturing step of 3 min at 96°C, followed by 25 cycles of 1 min at 96°C, 1 min at 55°C (55–60°C depending on primers), 1 min at 72°C, and a final step of 3 min at 72°C. PCR products were separated on a 2–2.5% agarose gel by electrophoresis and stained with ethidium bromide, and signal quantification was conducted by laser scanning densitometry, as reported previously (52).

The RT and PCR methods used in this work have been extensively validated in previous publications (13, 52). Each specific mRNA signal is normalized to its corresponding 18S. For each primer set, PCR conditions (cDNA dilutions, 18S competimer-primer mix, MgCl2 concentration, and annealing temperature) were set to optimal conditions, normalized so that the target mRNA product yields were in the linear range of the semilog plot when the yield is expressed as a function of the number of PCR cycles, and, for a given condition, 18S and target mRNA PCR yields were tightly correlated to input cDNA.

Statistical analysis.   All values are reported as means ± SE. Treatment effects were determined by ANOVA with repeated measures by using the Prism software package (Graphpad). Pearson's correlation analysis was used to assess the relationship between p21 and myogenin by using the Prism software package. For all statistical tests, the 0.05 level of confidence was accepted for statistical significance.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Analysis of the torque output records indicated that, over the two exercise sessions, the subjects produced 29 ± 3% of their previously measured isometric MVC during the NMES-induced high-force actions. The NMES current used to induce these isometric actions was 151 ± 15 mA.

Components of the IGF-I axis.   Expression and/or accumulation of mRNA for IGF-I was decreased by ~46% 12 h after a single session of NMES-induced high-force isometric actions (Fig. 2A). The level of MGF mRNA, the loading-sensitive isoform of IGF-I (25), was unchanged at all time points (not shown). The mRNA for IGFBP-4 was increased by 84% by a single session of NMES-induced high-force isometric actions, but this response decayed such that it was no longer elevated 24 h postexercise (Fig. 2B). The imposition of a second session of NMES-induced high-force isometric actions 24 h after the first resulted in an additional increase in IGFBP-4 mRNA to approximately twofold above the preexercise value that was sustained through 96-h postexercise (Fig. 2B). There were no changes in the levels of IGFBP-5 or the IGF-I receptor mRNAs at any time point (not shown).



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2. Components of the IGF-I axis. RE induced changes in the expression and/or accumulation of the mRNA for IGF-I (A) and IGF binding protein-4 (IGFBP-4; B). Values are means ± SE. Pre, preexercise. Solid symbols, samples collected at the indicated time points following a single bout of RE; open symbols, samples collected after the imposition of a second bout of RE, ~24 h after the initial bout (time 0, Fig. 1). *P < 0.05 vs. Pre. Representative gel images are presented as supplemental data (http://jap.physiology.org/cgi/content/full/00895.2004/DC1).

 
Myogenic regulatory factors.   The expression and/or accumulation of MyoD mRNA was increased by 83% 12 h after a single session of NMES-induced high-force isometric actions (Fig. 3A). The level of mRNA for myogenin was increased 2.8- to 3.1-fold at 12, 24, and 48 h postexercise (Fig. 3B).



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3. Myogenic regulatory factors. RE induced changes in the amount of mRNA for MyoD (A) and myogenin (B). Values are means ± SE. See Fig. 2 legend for explanation of symbols. * P < 0.05 vs. Pre. See supplemental data for representative gel images.

 
Markers of cellular proliferation and differentiation.   The mRNA for cyclin D1, a non-muscle-specific marker of cellular proliferation, was increased by 50% at 12 h after the first session of NMES-induced isometric actions (Fig. 4A). The mRNA for p21, a general marker of cellular differentiation, was increased 16- to 20-fold in the postexercise samples at 12, 24, and 48 h postexercise (Fig. 4B). There was a positive relation between myogenin and p21 mRNA when analyzed by individual data point (Fig. 5A) or by time point (Fig. 5B).



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 4. Markers of cellular proliferation and differentiation. RE induced changes in the amount of mRNA for cyclin D1 (A) and cyclin-dependent kinase inhibitor p21 (B). Values are means ± SE. See Fig. 2 legend for explanation of symbols. * P < 0.05 vs. Pre. See supplemental data for representative gel images.

 


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5. Relationship between myogenin and p21. There were significant positive correlations between the mRNA for p21 and myogenin. A: individual data points. B: data grouped by time point as indicated (n = 9, per data point). Values are means ± SE.

 
Total RNA concentration.   Total muscle RNA increased 96 h postexercise (Fig. 6).



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 6. RNA concentration. RE resulted in an increase in the concentration of total RNA at 96 h postexercise. Values are means ± SE. See Fig. 2 legend for explanation of symbols. * P < 0.05 vs. Pre.

 

    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
On a cellular level, the implicit aim of RE training programs, designed to induce skeletal muscle hypertrophy, is the optimal activation of the anabolic and myogenic mechanisms that result in the accretion of the proteins necessary to support an increase in myofiber size. Because these cellular-level mechanisms must be activated to achieve meaningful adaptations, their activation must precede these adaptations. As a matter of course, studies that involve the development of measurable adaptations, such as increased skeletal muscle or myofiber size, will not provide information on the dynamic state that exists as the adaptation processes are initiated.

In this study, we have used previously established molecular markers, representative of several cellular-level myogenic processes, to elucidate the time course of the response of human skeletal muscle to acute sessions of high-force isometric actions with a temporal resolution of hours rather than weeks. In contrast to voluntary muscle actions, NMES results in consistent, maximal activation of all effected myofibers with each stimulation. The design of the present study was closely patterned on our previous work conducted in rodents in an effort to translate those findings from the rat model to humans (3, 24).

Potential weaknesses.   Some compromises were made during the translation of the experimental design from rodents to humans. Specifically, a second session of high-force isometric actions was performed in the same subjects after just two single-session time point samples were obtained. This was done to avoid having to use a second cohort of subjects to complete this study. However, this approach sacrificed the potential to observe the decline in responses over time. In addition, fewer time points were used to reduce the number of biopsy samples that each subject was required to provide. Due to the size of the biopsy samples, the number and type of analysis targets were also reduced. Due to this limitation, we focused on mRNA-level analyses, which provided the greatest number of data points for a given tissue sample.

RE.   The high-force muscle contractions are common in RE and, as used in this study, were very similar to that used in our laboratory's previous work with rat and humans (3, 13, 24). As with our rodent and human studies, NMES was used to avoid the complications associated with voluntary contractile activity, including the problem of motor unit cycling, which would increase variability when using biopsy sampling (3, 13, 24). These foundational studies used isometric as opposed to dynamic muscle actions to reduce the possibility of skeletal muscle injury, which might tend to complicate the interpretation of results. While isometric-mode resistance training is currently less common, it has been shown to be effective in producing increases in muscle size and strength (e.g., Refs. 30, 36, 43).

IGF-I axis.   IGF-I has been shown to stimulate anabolic and myogenic processes associated with the development of skeletal muscle hypertrophy (1). In skeletal muscle, the IGF-I system has also been shown to be sensitive to increased loading (1, 2, 4, 24). In this tissue, the IGF-I axis consists of locally expressed IGF-I and MGF, the type I IGF-I receptor, and a number of IGF-I binding proteins. Modulation of the various components of this system appears to be important for a compensatory hypertrophic response (1, 8, 9, 12, 19, 23, 25, 32, 51). In humans, RE has been variously reported to increase (Ref. 11; lengthening muscle actions), decrease (39), or not change (13, 26) IGF-I mRNA levels. We had previously reported that our acute RE protocol resulted in increased IGF-I mRNA in rodents (24). In contrast to that result, in the present study, IGF-I mRNA was found to decrease by almost 50% at the earliest time point (Fig. 2A). Using a different exercise program (e.g., 250–350 dynamic contractions), Psilander et al. (39) also found that IGF-I mRNA was modestly decreased 1–6 h postexercise. We had previously found that IGF-I mRNA was unchanged 24 h after two bouts of RE in humans, which would agree with our current findings (13). In animal studies, increased skeletal muscle loading has been shown to result in an upregulation of the expression of IGFBP-4 and downregulation of IGFBP-5 (8, 24). In the present study, we found that the mRNA for IGFBP-4 was increased 12 h after a single bout of RE and then started to return toward control by 24 h. The second bout of RE conducted after the 24-h time point resulted in a further increase in the mRNA for IGFBP-4. In a possible contrast, Bamman et al. (11) found that RE involving lengthening skeletal muscle actions resulted in a decrease in IGFBP-4 mRNA. Unlike the results from rodent studies, we did not find that the mRNA for IGFBP-5 was depressed following RE (8, 24). Also, in contrast to our previous rodent studies, we did not see an increase in MGF mRNA following RE (24). In agreement with this result, we had previously found that two bouts of RE resulted in an increase in MGF mRNA in spinal cord injury but not control subjects (13).

Myogenic regulatory factors.   The myogenic regulatory factor (MRF) family is made up of a set of transcription factors that determine the myogenic fate of cells. Although various members of this family may have overlapping functions, specific roles for the various MRFs have been proposed. MyoD is most often associated with cell determination and is often found to be highly expressed in actively proliferating myoblasts and may be critical for proliferation in response to stimuli such as skeletal muscle injury (34, 44, 48, 50). Increased expression of myogenin is often associated with committed stages of myoblast differentiation and fusion (22, 27, 44, 48, 53). Alternatively, myogenin expression may occur within myofibers and may be associated with alterations in metabolic properties (31).

In the present study, the expression and/or accumulation of MyoD mRNA was modestly increased 12 h after the initial bout of RE (Fig. 3A). However, the subsequent bout of RE did not stimulate an increase in MyoD. Psilander et al. (39) also reported a transient increase in MyoD mRNA immediately following their RE bouts.

The mRNA for myogenin experienced a fairly robust increase in response to RE that was maintained through the 24-h time point (Fig. 3B). The second bout of RE resulted in a renewed or continued elevation of myogenin mRNA that decayed by the final 96-h time point (i.e., 72 h later).

Cell proliferation and differentiation.   In contrast to the MRFs, markers such as cyclin D1 and cyclin-dependent kinase inhibitor p21 are generalized or nonskeletal muscle cell-specific markers of potential proliferation (cyclin D1) or differentiation (p21; p21 is a cell cycle inhibitor). In rats, we found that cyclin D1 mRNA was relatively insensitive to a single bout of RE but responded with an approximately twofold increase following a second RE bout (24). In the present study, we found that cyclin D1 was increased only at the earliest post-RE time point and only by ~50% (Fig. 4A). An elevation of cyclin D1 expression would suggest an increase in the number of cells within the previously exercised muscles that are activated to enter the cell cycle in response to this stimulus. Visual comparisons between the cyclin D1 and MyoD data appear to suggest that these two message pools were responding in a similar manner (Figs. 3A and 4A). However, there was no significant correlative relationship between these two data sets (data not shown).

The mRNA for p21 demonstrated the most dramatic magnitude of change of any of the markers analyzed for this study (Fig. 4B). The cyclin-dependent kinase inhibitor p21 is associated with withdrawal from the cell cycle and, often, subsequent cell differentiation (22). Because there did not appear to be a high signal indicating proliferative activity, the increased expression of p21 mRNA suggests that a number of cells within the exercised skeletal muscles were most likely going through the process differentiation. As our laboratory has reported in a number of previous studies involving increased skeletal muscle loading (4, 13, 24), there was a strong correlation between the mRNA for myogenin and that of p21 (Fig. 5A). Further analysis indicated that this relationship retained temporal coherence (Fig. 5B). These results strongly suggest that at least some of the cells going through the process of differentiation were myogenic precursor cells.

Total RNA.   The majority of the RNA present in skeletal muscle cells consists of ribosomal RNA. Therefore, the concentration of RNA in skeletal muscle provides an indication of the synthetic potential of the cells that make up that tissue. However, it should be noted that potential differences in translational efficiency would not necessarily be reflected in this measurement. In a previous study, we found that the concentration of RNA in skeletal muscle of spinal cord injury subjects before the RE bouts was lower than that in skeletal muscle of able-bodied control subjects but that, after exercise, the RNA concentration was not different between these two groups (13). In skeletal muscle from the able-bodied subjects, two sessions of RE did not result in any changes in RNA when measured 24 h postexercise, a result that is similar to that seen in the present study (13). However, herein we report that two sessions of exercise did induce an increase in RNA at the 96-h time point (72 h after the second RE bout). This suggests that the anabolic potential of these skeletal muscles was increasing after just two sessions of RE but with a substantial delay relative to the molecular markers.

Exercise mode.   The question arises whether the exercise mode used in this study may account for differences with published results using dynamic muscle actions. For example, in one such study, Bamman et al. (11) had subjects complete eight sets of eight squat exercises on two different occasions. In one session, shortening muscle actions were performed; in the other session, lengthening actions were performed. Muscle biopsies were collected 48 h postexercise in each case. These authors reported that the mRNA for IGFBP-4 was decreased and that of IGF-I increased in response to lengthening contractions conducted at 110% of one repetition maximum (11). Compared with the present results using isometric RE (Fig. 2), this indicates that lengthening muscle contractions may lead to a difference in adaptation, either in magnitude or time course. However, it should be noted that, at the 48-h time point, following the lengthening but not shortening contractions, these subjects reported high levels of soreness, had reduced MVC, and had serum creatine kinase levels that were approximately threefold higher than baseline measurements. Therefore, it is not clear whether the changes seen were related to nascent adaptive responses or to muscle injury.

In a more recent study, Bamman et al. (10) measured the expression of MRF and cell cycle-related proteins in the muscles of young and old subjects of both genders, before and after dynamic-mode RE. In that study, the RE consisted of three sets of three different dynamic REs designed to recruit the quadriceps muscle group for shortening or shortening plus lengthening muscle contractions (10). In biopsy samples collected 24 h postexercise, no changes were detected in protein levels of the MRFs or the cyclins measured. These authors did observe a decrease in the levels of cyclin-dependent kinase inhibitor p27 in female subjects postexercise. In the context of the present study, it is not clear whether these results represent RE mode-specific differences or a latency in the translation of MRF and cyclin mRNAs.

Our laboratory recently reported that, following resistance training programs that resulted in muscle hypertrophy in rats, significantly elevated levels of MGF and IGF-I mRNA could be detected in the muscles of animals that had been trained using either isometric or shortening but not lengthening muscle contractions (3). However, due to the experimental design, it cannot be determined whether these results represent mode-specific responses to the last bout of RE or a different steady state induced by 10 serial bouts of RE training.

Perhaps the most compelling argument for a mode-specific difference in molecular level responses to RE comes from the work published by Hameed et al. (26). In that study, subjects completed 10 sets of knee extensor exercise at 80% of one repetition maximum with muscle biopsies of the VL collected at 2.5 h postexercise. These authors report that RE induced an increase (range, 2–864%) in the mRNA for MGF in the muscles of young but not old subjects, whereas no RE-induced change in IGF-I mRNA was detected. Whereas the results presented herein do not include a postexercise time point before 12 h, the findings published by Hameed et al. may suggest that exercise mode plays a role in determining the pattern of molecular level responses to RE.

In summary, the results of this study indicate that a single session of RE is sufficient to stimulate molecular-level responses, which is indicative of the initiation of myogenic processes in skeletal muscle. It is important to note that the RE session used in this study consisted of a total of 90 electrically stimulated contractions with a total duty cycle of 7.5 min of contractile activity. Just two bouts of this activity, a total of 14 min of contraction spread over 2 days, was sufficient to induce an increase in the concentration of total RNA, most likely representing an increase in ribosomal RNA, and, therefore, an increase in the anabolic potential of this tissue. These results, along with a number of other published observations, indicate that the mechanisms that regulate the adaptation of skeletal muscle to increased loading respond on a relatively short time scale and that these responses may be useful in evaluating RE training variables with high temporal resolution.


    GRANTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Funding was provided, in part, by the Foundation for Physical Therapy (C. S. Bickel) and National Institutes of Health Grants HD-37439-S, HD-39676, and HD-39676-S2 (to G. A. Dudley) and AR-45594 (to G. R. Adams).


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
The authors thank the subjects for their participation, particularly their willingness to provide multiple biopsy samples. We also acknowledge Anqi Qin for technical assistance with the molecular analysis.


    FOOTNOTES
 

Address for reprint requests and other correspondence: G. R. Adams, Dept. of Physiology & Biophysics, Univ. of California, Irvine, Medical Sciences 1, Rm. D335, Irvine, CA 92697-4560 (E-mail: GRAdams{at}uci.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 

  1. Adams GR. Role of insulin-like growth factor-I in the regulation of skeletal muscle adaptation to increased loading. Exerc Sport Sci Rev 26: 31–60, 1998.[Web of Science][Medline]
  2. Adams GR, Caiozzo VJ, Haddad F, and Baldwin KM. Cellular and molecular responses to increased skeletal muscle loading after irradiation. Am J Physiol Cell Physiol 283: C1182–C1195, 2002.[Abstract/Free Full Text]
  3. Adams GR, Cheng DC, Haddad F, and Baldwin KM. Skeletal muscle hypertrophy in response to isometric, lengthening, and shortening training bouts of equivalent duration. J Appl Physiol 96: 1613–1618, 2004.[Abstract/Free Full Text]
  4. Adams GR, Haddad F, and Baldwin KM. Time course of changes in markers of myogenesis in overloaded rat skeletal muscles. J Appl Physiol 87: 1705–1712, 1999.[Abstract/Free Full Text]
  5. Adams GR, Harris RT, Woodard D, and Dudley GA. Mapping of electrical muscle stimulation using MRI. J Appl Physiol 74: 532–537, 1993.[Abstract/Free Full Text]
  6. Akima H, Foley JM, Prior BM, Dudley GA, and Meyer RA. Vastus lateralis fatigue alters recruitment of musculus quadriceps femoris in humans. J Appl Physiol 92: 679–684, 2002.[Abstract/Free Full Text]
  7. Allen DL, Monke SR, Talmadge RJ, Roy RR, and Edgerton VR. Plasticity of myonuclear number in hypertrophied and atrophied mammalian skeletal muscle fibers. J Appl Physiol 78: 1969–1976, 1995.[Abstract/Free Full Text]
  8. Awede B, Thissen J, Gailly P, and Lebacq J. Regulation of IGF-I, IGFBP-4 and IGFBP-5 gene expression by loading in mouse skeletal muscle. FEBS Lett 461: 263–267, 1999.[CrossRef][Web of Science][Medline]
  9. Awede BL, Thissen JP, and Lebacq J. Role of IGF-I and IGFBPs in the changes of mass and phenotype induced in rat soleus muscle by clenbuterol. Am J Physiol Endocrinol Metab 282: E31–E37, 2002.[Abstract/Free Full Text]
  10. Bamman MM, Ragan RC, Kim JS, Cross JM, Hill VJ, Tuggle SC, and Allman RM. Myogenic protein expression before and after resistance loading in 26- and 64-yr-old men and women. J Appl Physiol 97: 1329–1337, 2004.[Abstract/Free Full Text]
  11. Bamman MM, Shipp JR, Jiang J, Gower BA, Hunter GR, Goodman A, McLafferty CL, and Urban RJ. Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans. Am J Physiol Endocrinol Metab 280: E383–E390, 2001.[Abstract/Free Full Text]
  12. Baxter RC. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278: E967–E976, 2000.[Abstract/Free Full Text]
  13. Bickel CS, Slade JM, Haddad F, Adams GR, and Dudley GA. Acute molecular responses of skeletal muscle to resistance exercise in able-bodied and spinal cord-injured subjects. J Appl Physiol 94: 2255–2262, 2003.[Abstract/Free Full Text]
  14. Booth FW and Baldwin KM. Muscle plasticity: energy demand and supply processes. In: Handbook of Physiology. Exercise: Regulation and Integration of Multiple Systems. Bethesda, MD: Am. Physiol. Soc., 1966, sect. 12, chapt. 24, p. 1074–1123.
  15. Booth FW, Tseng BS, Fluck M, and Carson JA. Molecular and cellular adaptation of muscle in response to physical training. Acta Physiol Scand 162: 343–350, 1998.[CrossRef][Web of Science][Medline]
  16. Castro MJ, Apple DF, Staron RS, Campos GER, and Dudley GA. Influence of complete spinal cord injury on skeletal muscle within 6 mo of injury. J Appl Physiol 86: 350–358, 1999.[Abstract/Free Full Text]
  17. Chomczynski P and Sacchi N. Single step method of RNA isolation by acid guanidimium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159, 1987.[Web of Science][Medline]
  18. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, and Florini JR. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 272: 6653–6662, 1997.[Abstract/Free Full Text]
  19. Damon SE, Haugk KL, Birnbaum RS, and Quinn LS. Retrovirally mediated overexpression of insulin-like growth factor binding protein 4: evidence that insulin-like growth factor is required for skeletal muscle differentiation. J Cell Physiol 175: 109–120, 1998.[CrossRef][Web of Science][Medline]
  20. Degens H, Meessen NEL, Wirtz P, and Binkhorst RA. The development of compensatory hypertrophy in the plantaris muscle of the rat. Ann Anat: 285–289, 1995.
  21. Dunn SE, Burns JL, and Michel RN. Calcineurin is required for skeletal muscle hypertrophy. J Biol Chem 274: 21908–21912, 1999.[Abstract/Free Full Text]
  22. Florini JR and Ewton DZ. Highly specific inhibition of IGF-I-stimulated differentiation by an antisense oligodeoxyribonucleotide to myogenin mRNA. J Biol Chem 265: 13435–13437, 1990.[Abstract/Free Full Text]
  23. Florini JR, Ewton DZ, and Coolican SA. Growth hormone and insulin like growth factor system in myogenesis. Endocr Rev 17: 481–517, 1996.[Abstract/Free Full Text]
  24. Haddad F and Adams GR. Acute cellular and molecular responses to resistance exercise. J Appl Physiol 93: 394–403, 2002.[Abstract/Free Full Text]
  25. Hameed M, Harridge SDR, and Goldspink G. Sarcopenia and hypertrophy: a role for insulin-like growth factor-1 in aged muscle? Exerc Sport Sci Rev 30: 15–19, 2002.[CrossRef][Web of Science][Medline]
  26. Hameed M, Orrell RW, Cobbold M, Goldspink G, and Harridge SD. Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J Physiol 547: 247–254, 2003.[Abstract/Free Full Text]
  27. Hasty P, Bradley A, Morris JH, Edmondson DG, Venuti JM, Olson EN, and Klein WH. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364: 501–506, 1993.[CrossRef][Medline]
  28. Hather BM, Adams GR, Tesch PA, and Dudley GA. Skeletal muscle responses to lower limb suspension in humans. J Appl Physiol 72: 1493–1498, 1992.[Abstract/Free Full Text]
  29. Hillegass EA and Dudley GA. Surface electrical stimulation of skeletal muscle after spinal cord injury. Spinal Cord 37: 251–257, 1999.[CrossRef][Web of Science][Medline]
  30. Jones DA and Rutherford OM. Human muscle strength training: the effects of three different regimes and the nature of the resultant changes. J Physiol 391: 1–11, 1987.[Abstract/Free Full Text]
  31. Kadi F, Johansson F, Johansson R, Sjostrom M, and Henriksson J. Effects of one bout of endurance exercise on the expression of myogenin in human quadriceps muscle. Histochem Cell Biol 121: 329–334, 2004.[CrossRef][Web of Science][Medline]
  32. Keller HL, St. Pierre Schneider B, Eppihimer LA, and Cannon JG. Association of IGF-I and IGF-II with myofiber regeneration in vivo. Muscle Nerve 22: 347–354, 1999.[CrossRef][Web of Science][Medline]
  33. Kong KY and Kedes L. Cytoplasmic nuclear transfer of the actin-capping protein tropomodulin. J Biol Chem 279: 30856–30864, 2004.[Abstract/Free Full Text]
  34. Lasser AB, Skapek SX, and Novitch B. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr Opin Cell Biol 6: 788–794, 1994.[CrossRef][Web of Science][Medline]
  35. Lexell J and Taylor CC. A morphometrical comparison of right and left whole human vastus lateralis muscle: how to reduce sampling errors in biopsy techniques. Clin Physiol 11: 271–276, 1991.[Web of Science][Medline]
  36. Morissey MC, Harman EA, and Johnson MJ. Resistance training modes: specificity and effectiveness. Med Sci Sports Exerc 27: 648–660, 1995.[Web of Science][Medline]
  37. Mozdziak PE, Greaser ML, and Schultz E. Myogenin, MyoD, and myosin expression after pharmacologically and surgically induced hypertrophy. J Appl Physiol 84: 1359–1364, 1998.[Abstract/Free Full Text]
  38. Obaya AJ and Sedivy JM. Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol Life Sci 59: 126–142, 2002.[CrossRef][Web of Science][Medline]
  39. Psilander N, Damsgaard R, and Pilegaard H. Resistance exercise alters MRF and IGF-I mRNA content in human skeletal muscle. J Appl Physiol 95: 1038–1044, 2003.[Abstract/Free Full Text]
  40. Quinn LS, Haugk KL, and Grabstein KH. Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology 136: 3669–3672, 1995.[Abstract]
  41. Rosenblatt DJ and Parry DJ. Gamma irradiation prevents compensatory hypertrophy of overloaded mouse extensor digitorum longus msucle. J Appl Physiol 73: 2538–2543, 1992.[Abstract/Free Full Text]
  42. Rosenblatt JD, Yong D, and Parry DJ. Satellite cell activity is required for hypertrophy of overloaded adult rat skeletal muscle. Muscle Nerve 17: 608–613, 1994.[CrossRef][Web of Science][Medline]
  43. Ruther CL, Golden CL, Harris RT, and Dudley GA. Hypertrophy, resistance training, and the nature of skeletal muscle activation. J Strength Cond Res 9: 155–159, 1995.[CrossRef]
  44. Sabourin LA and Rudnicki MA. The molecular regulation of myogenesis. Clin Genet 57: 16–25, 2000.[CrossRef][Web of Science][Medline]
  45. Salleo A, LaSpada G, Falzea G, Denaro MG, and Cicciarello R. Response of satellite cells and muscle fibers to long-term compensatory hypertrophy. J Submicrosc Cytol Pathol 15: 929–940, 1983.
  46. Schiaffino S, Bormioli SP, and Aloisi M. Cell proliferation in rat skeletal muscle during early stages of compensatory hypertrophy. Virchows Arch B Cell Pathol 11: 268–273, 1972.[Medline]
  47. Schiaffino S, Pierobon Bormioli S, and Aloisi M. The fate of newly formed satellite cells during compensatory muscle hypertrophy. Virchows Arch B Cell Pathol 21: 113–118, 1976.[Web of Science][Medline]
  48. Seale P and Rudnicki MA. A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Dev Biol 218: 115–124, 2000.[CrossRef][Web of Science][Medline]
  49. Snow MH. Satellite cell response in rat soleus muscle undergoing hypertrophy due to surgical ablation of synergists. Anat Rec 227: 437–446, 1990.[CrossRef][Medline]
  50. Taylor JM, Dupont-Versteegden EE, Davies JD, Hassell JA, Houle JD, Gurley CM, and Peterson CA. A role for the ETS domain transcription factor PEA3 in myogenic differentiation. Mol Cell Biol 17: 5550–5559, 1997.[Abstract]
  51. Valentinis B and Baserga R. IGF-I receptor signaling in transformation and differentiation. Mol Pathol 54: 133–137, 2001.[Abstract/Free Full Text]
  52. Wright C, Haddad F, Qin A, and Baldwin KM. Analysis of myosin heavy chain mRNA expression by RT-PCR. J Appl Physiol 83: 1389–1396, 1997.[Abstract/Free Full Text]
  53. Zhang P, Wong C, Liu D, Finegold M, Harper JW, and Elledge SJ. p21 CIP1 and p57 KIP2 control muscle differentiation at the myogenin step. Genes Dev 13: 213–224, 1999.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
In VivoHome page
A. PHILIPPOU, E. PAPAGEORGIOU, G. BOGDANIS, A. HALAPAS, A. SOURLA, M. MARIDAKI, N. PISSIMISSIS, and M. KOUTSILIERIS
Expression of IGF-1 Isoforms after Exercise-induced Muscle Damage in Humans: Characterization of the MGF E Peptide Actions In Vitro
In Vivo, July 1, 2009; 23(4): 567 - 575.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. J. Drummond, M. Miyazaki, H. C. Dreyer, B. Pennings, S. Dhanani, E. Volpi, K. A. Esser, and B. B. Rasmussen
Expression of growth-related genes in young and older human skeletal muscle following an acute stimulation of protein synthesis
J Appl Physiol, April 1, 2009; 106(4): 1403 - 1411.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Lehti, R. Kivela, P. Komi, J. Komulainen, H. Kainulainen, and H. Kyrolainen
Effects of fatiguing jumping exercise on mRNA expression of titin-complex proteins and calpains
J Appl Physiol, April 1, 2009; 106(4): 1419 - 1424.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
V. G. Coffey, H. Pilegaard, A. P. Garnham, B. J. O'Brien, and J. A. Hawley
Consecutive bouts of diverse contractile activity alter acute responses in human skeletal muscle
J Appl Physiol, April 1, 2009; 106(4): 1187 - 1197.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. W. Bodell, E. Kodesh, F. Haddad, F. P. Zaldivar, D. M. Cooper, and G. R. Adams
Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise
J Appl Physiol, February 1, 2009; 106(2): 443 - 453.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Drummond, J. J. McCarthy, C. S. Fry, K. A. Esser, and B. B. Rasmussen
Aging differentially affects human skeletal muscle microRNA expression at rest and after an anabolic stimulus of resistance exercise and essential amino acids
Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1333 - E1340.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
B. R. McKay, C. E. O'Reilly, S. M. Phillips, M. A. Tarnopolsky, and G. Parise
Co-expression of IGF-1 family members with myogenic regulatory factors following acute damaging muscle-lengthening contractions in humans
J. Physiol., November 15, 2008; 586(22): 5549 - 5560.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. J. Wacker, M. M. Tehel, and P. M. Gallagher
Technique for quantitative RT-PCR analysis directly from single muscle fibers
J Appl Physiol, July 1, 2008; 105(1): 308 - 315.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. Deldicque, P. Atherton, R. Patel, D. Theisen, H. Nielens, M. J. Rennie, and M. Francaux
Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle
J Appl Physiol, February 1, 2008; 104(2): 371 - 378.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J.-s. Kim, J. K. Petrella, J. M. Cross, and M. M. Bamman
Load-mediated downregulation of myostatin mRNA is not sufficient to promote myofiber hypertrophy in humans: a cluster analysis
J Appl Physiol, November 1, 2007; 103(5): 1488 - 1495.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. Louis, U. Raue, Y. Yang, B. Jemiolo, and S. Trappe
Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle
J Appl Physiol, November 1, 2007; 103(5): 1744 - 1751.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. R. Adams, F. Haddad, P. W. Bodell, P. D. Tran, and K. M. Baldwin
Combined isometric, concentric, and eccentric resistance exercise prevents unloading-induced muscle atrophy in rats
J Appl Physiol, November 1, 2007; 103(5): 1644 - 1654.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
U Berg, T Gustafsson, C J Sundberg, L Kaijser, C Carlsson-Skwirut, and P Bang
Interstitial IGF-I in exercising skeletal muscle in women
Eur. J. Endocrinol., October 1, 2007; 157(4): 427 - 435.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. M. Bamman, J. K. Petrella, J.-s. Kim, D. L. Mayhew, and J. M. Cross
Cluster analysis tests the importance of myogenic gene expression during myofiber hypertrophy in humans
J Appl Physiol, June 1, 2007; 102(6): 2232 - 2239.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. G. Churchley, V. G. Coffey, D. J. Pedersen, A. Shield, K. A. Carey, D. Cameron-Smith, and J. A. Hawley
Influence of preexercise muscle glycogen content on transcriptional activity of metabolic and myogenic genes in well-trained humans
J Appl Physiol, April 1, 2007; 102(4): 1604 - 1611.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
T. Kvorning, M. Andersen, K. Brixen, P. Schjerling, C. Suetta, and K. Madsen
Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans
J. Physiol., January 15, 2007; 578(2): 579 - 593.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. Garma, C. Kobayashi, F. Haddad, G. R. Adams, P. W. Bodell, and K. M. Baldwin
Similar acute molecular responses to equivalent volumes of isometric, lengthening, or shortening mode resistance exercise
J Appl Physiol, January 1, 2007; 102(1): 135 - 143.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
O. R. Seynnes, M. de Boer, and M. V. Narici
Early skeletal muscle hypertrophy and architectural changes in response to high-intensity resistance training
J Appl Physiol, January 1, 2007; 102(1): 368 - 373.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. K. Petrella, J.-s. Kim, J. M. Cross, D. J. Kosek, and M. M. Bamman
Efficacy of myonuclear addition may explain differential myofiber growth among resistance-trained young and older men and women
Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E937 - E946.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. J. Kosek, J.-s. Kim, J. K. Petrella, J. M. Cross, and M. M. Bamman
Efficacy of 3 days/wk resistance training on myofiber hypertrophy and myogenic mechanisms in young vs. older adults
J Appl Physiol, August 1, 2006; 101(2): 531 - 544.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
U. Raue, D. Slivka, B. Jemiolo, C. Hollon, and S. Trappe
Myogenic gene expression at rest and after a bout of resistance exercise in young (18-30 yr) and old (80-89 yr) women
J Appl Physiol, July 1, 2006; 101(1): 53 - 59.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. G. Coffey, A. Shield, B. J. Canny, K. A. Carey, D. Cameron-Smith, and J. A. Hawley
Interaction of contractile activity and training history on mRNA abundance in skeletal muscle from trained athletes
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E849 - E855.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
F. Haddad and G. R. Adams
Aging-sensitive cellular and molecular mechanisms associated with skeletal muscle hypertrophy
J Appl Physiol, April 1, 2006; 100(4): 1188 - 1203.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J.-s. Kim, D. J. Kosek, J. K. Petrella, J. M. Cross, and M. M. Bamman
Resting and load-induced levels of myogenic gene transcripts differ between older adults with demonstrable sarcopenia and young men and women
J Appl Physiol, December 1, 2005; 99(6): 2149 - 2158.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. B. Reid
Response of the ubiquitin-proteasome pathway to changes in muscle activity
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1423 - R1431.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y. Yang, A. Creer, B. Jemiolo, and S. Trappe
Time course of myogenic and metabolic gene expression in response to acute exercise in human skeletal muscle
J Appl Physiol, May 1, 2005; 98(5): 1745 - 1752.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Supplementary Material
Right arrow All Versions of this Article:
98/2/482    most recent
00895.2004v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bickel, C. S.
Right arrow Articles by Adams, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bickel, C. S.
Right arrow Articles by Adams, G. R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.